NL-OMON32927已完成不适用
An open, randomised, single center study to compare a low suction intra and postoperative autologous blood transfusion system with no drainsystem at all with regards to haemoglobin loss following primary total hip arthroplasty implantation - Comparison of a bloodtransfusion system with no drain, during hipsurgery
Isala Klinieken0 个研究点目标入组 214 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 214
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •age 18 years and up
- •provision of written informed consent
- •the patient is subject to a total hip arthroplasty implantation
排除标准
- •coagulation disorders, including thrombo embolic history
- •ongoing infections
- •untreated hypertension
- •renal dysfunction
- •unstable angina pectoris
- •myocardial infarction within the past 12 months
- •bypass-operation within the past 12 months
- •intake of anticoagulants
- •participation in other clinical trials dealing with any drugs which influences blood loss
研究者
相似试验
招募中
不适用
An open randomised single center study to compare a low suction intra and postoperative autologous blood transfusion system with a high suction drainage system with regards to haemoglobin loss following primary total hip arthroplastyhip replacement operationtotal hip arthroplasty10023213NL-OMON31824Isala Klinieken100
进行中（未招募）
1 期
An open, randomised, multicentre study to compare buprenorphine transdermal delivery system (BTDS) with standard treatment in elderly subjects with OA of the hip and/or knee.Severe osteoarthritic pain of the hip(s) and/or knee(s)MedDRA version: 8.0 Level: PT Classification code 10003239EUCTR2005-004279-39-GBapp Pharmaceuticals Limited
进行中（未招募）
不适用
A randomised, open label, multicenter study comparing the efficacy and safety of medical treatment with Sandostatin LAR 30 mg administered every 21 days for 6 months with that of Sandostatin LAR 60 mg administered every 28 days for 6 months in acromegalic patients with uncontrolled diseaseTreatment of acromegalic patients partially responsive to somatostatin analoguesMedDRA version: 6.1Level: PTClassification code 10000599EUCTR2005-003444-53-ITOVARTIS FARMA50
尚未招募
不适用
Study of efficacy and safety of FormairCTRI/2017/01/007711Rus Biopharm150
进行中（未招募）
不适用
Study to compare the efficacy of diuretics in patients in hemodialysis with residual diuresisChronic renal disease stage V in hemodialysisMedDRA version: 16.0Level: LLTClassification code 10051051Term: Renal diseaseSystem Organ Class: 100000004857EUCTR2013-003214-41-ESFundació Parc Taulí